Memantine is an NMDA receptor antagonist that modulates glutamatergic neurotransmission, potentially reducing neuronal hyperexcitability associated with Visual Snow Syndrome. By blocking excessive glutamate signaling, it may help mitigate the aberrant cortical processing and neurological symptoms characteristic of the condition, offering a potential therapeutic approach for managing visual disturbances.